The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term follow up for a phase I trial HER2/neu-targeted T cells in women with advanced breast cancer.
Lawrence G. Lum
Employment or Leadership Position - TransTarget (U)
Consultant or Advisory Role - TransTarget (U)
Stock Ownership - TransTarget
Archana Thakur
No relevant relationships to disclose
Zaid S. Al-Kadhimi
No relevant relationships to disclose
Gerald A. Colvin
No relevant relationships to disclose
Francis J. Cummings
No relevant relationships to disclose
Robert Duffy Legare
No relevant relationships to disclose
Don S. Dizon
No relevant relationships to disclose
Nicola Kouttab
No relevant relationships to disclose
Abby Maizel
No relevant relationships to disclose
William Colaiace
No relevant relationships to disclose
Qin Liu
No relevant relationships to disclose
Ritesh Rathore
No relevant relationships to disclose